Keywords: fujisawa, prograf, approved, liver, transplants, usa, food

FUJISAWA'S PROGRAF APPROVED FOR LIVER TRANSPLANTS IN USA

Article | 18 April 1994

Print This

The US Food and Drug Administration last week granted marketing approval for Fujisawa' USA Inc's Prograf (tacrolimus; formerly FK-506) for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in